Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymund Buhmann

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cellular Immunology|March 30, 2010
Canine-DCs using different serum-free methods as an approach to provide an animal-model for immunotherapeutic strategiesDagmar Bund, Raymund Buhmann, Füsun Gökmen, et al.
British Journal of Haematology|August 30, 2002
CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cellsRaymund Buhmann, Christian Kurzeder, Jutta Rehklau, et al.
Journal of Clinical and Experimental Hepatology|October 6, 2025
Exploring the Impact of Therapeutic Plasma Exchange on Organ Function in Patients With ACLF: A Retrospective, Single-center Propensity Score-matched Cohort StudyJonas Schumacher, Reinhard Henschler, Raymund Buhmann, et al.
Blood|September 24, 2005
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemiaChristine Mayr, Michael R Speicher, David M Kofler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulationsJulia Schick, Valentin Vogt, Marion Zerwes, et al.
Clinical and Experimental Medicine|March 24, 2012
In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotypingSusanne Reuther, Helga Schmetzer, Friedhelm R Schuster, et al.
Journal of Clinical Virology Plus|March 9, 2022
Sensitivity of SARS-CoV-2 antibody tests with late convalescent seraJudith Kannenberg, Carolin Schnurra, Nina Reiners, et al.
Biomedical Optics Express|October 28, 2015
Handheld imaging photonic crystal biosensor for multiplexed, label-free protein detectionSabrina Jahns, Marion Bräu, Björn-Ole Meyer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2014
Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cellsValentin Vogt, Julia Schick, Christian Ansprenger, et al.
British Journal of Haematology|December 16, 2014
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignanciesFriedhelm R Schuster, Michael Stanglmaier, Wilhelm Woessmann, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cellular Immunology|March 30, 2010
Canine-DCs using different serum-free methods as an approach to provide an animal-model for immunotherapeutic strategiesDagmar Bund, Raymund Buhmann, Füsun Gökmen, et al.
British Journal of Haematology|August 30, 2002
CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cellsRaymund Buhmann, Christian Kurzeder, Jutta Rehklau, et al.
Journal of Clinical and Experimental Hepatology|October 6, 2025
Exploring the Impact of Therapeutic Plasma Exchange on Organ Function in Patients With ACLF: A Retrospective, Single-center Propensity Score-matched Cohort StudyJonas Schumacher, Reinhard Henschler, Raymund Buhmann, et al.
Blood|September 24, 2005
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemiaChristine Mayr, Michael R Speicher, David M Kofler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulationsJulia Schick, Valentin Vogt, Marion Zerwes, et al.
Clinical and Experimental Medicine|March 24, 2012
In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotypingSusanne Reuther, Helga Schmetzer, Friedhelm R Schuster, et al.
Journal of Clinical Virology Plus|March 9, 2022
Sensitivity of SARS-CoV-2 antibody tests with late convalescent seraJudith Kannenberg, Carolin Schnurra, Nina Reiners, et al.
Biomedical Optics Express|October 28, 2015
Handheld imaging photonic crystal biosensor for multiplexed, label-free protein detectionSabrina Jahns, Marion Bräu, Björn-Ole Meyer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2014
Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cellsValentin Vogt, Julia Schick, Christian Ansprenger, et al.
British Journal of Haematology|December 16, 2014
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignanciesFriedhelm R Schuster, Michael Stanglmaier, Wilhelm Woessmann, et al.
Pageof 3